Blog Posts

Three 340B Terminations, Seven Paybacks to Manufacturers in Latest Provider Audit Findings

Federal regulators released a March 20 update to ongoing 340B program integrity audits for fiscal year 2023.
Federal auditors determined terminations from the 340B program were required for either a covered entity site or a contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Mark Ogunsusi, Associate, Powers Law Firm

Mark Ogunsusi

Q: Where did you grow up?

I grew up in Atlanta, Georgia.  As a teenager, I was exposed to several healthcare professional settings, and I had the opportunity to

Read More »

Breaking News

West Virginia Becomes Third State to Enact 340B Contract Pharmacy Protection Law

W.Va. Gov. Jim Justice (R) signed a bill prohibiting drugmaker 340B contract pharmacy restrictions, which will take effect on June 6.
West Virginia Gov. Jim Justice (R) signed into law today a bill to prohibit drugmaker 340B contract pharmacy restrictions, making [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Kansas State Lawmakers Pass 340B Contract Pharmacy Protections in Separate Budget Bills But Face Resistance from House Speaker and Certain Advocacy Groups

Both Kansas state legislative chambers passed budget bills that included amendments to bar drugmaker 340B contract pharmacy restrictions.
The Kansas state house and senate have passed separate budget bills with late added amendments to prohibit drugmaker 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

As Arkansas Prepares to Enforce 340B Contract Pharmacy Law, Major Drugmaker Files Suit and PhRMA Plans to Seek 8th Circuit Rehearing

Drugmaker AstraZeneca filed suit against Arkansas' 340B contract pharmacy law, shortly after it was upheld by a federal appeals court.
After a federal appeals court upheld Arkansas’ 340B contract pharmacy access law, a major drug manufacturer has asked a federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Leveraging Cash Cards to Amplify Your Patient Impact

Larry Crowder headshot

SPONSORED CONTENT

With impending changes like the Senate’s bipartisan SUSTAIN 340B Act on the horizon, it’s becoming increasingly critical for covered entities to demonstrate tangible benefits and positive patient outcomes because of their participation in the 340B program. In the article below, Larry Crowder, Vice President of 340B at Cervey, explores an innovative strategy to ensure compliance and enhance the effectiveness of the 340B program – the cash card.

Understanding Cash Cards: Cash cards allow covered entities (CE) to provide financial assistance directly into the hand of those patients who need it most. These programs typically involve distributing a letter containing payor information – the BIN/PCN associated with a specific insurance or payment network to a patient who meets certain criteria which allows them to receive discounted or free prescriptions at a partnering retail pharmacy. Patients can use these “cards” to receive a lower co-pay and/or drug cost or,

Read More »

Influential House GOP Group Calls for Major Medicaid Cuts and 340B Revenue to ‘Go Where Intended’

The Republican Study Committee's proposed fiscal year 2025 budget includes calls for changes to the 340B program.
An influential conservative congressional caucus is urging Congress to significantly cut Medicaid spending and “ to ensure that drug discounts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Judge Dismisses Health System’s Penny Pricing Coordination Lawsuit Against Drugmakers

A federal district judge has dismissed Calif.-based Adventist West's lawsuit against four drug manufacturers.
A federal judge recently dismissed a large California health system’s whistleblower case against four pharmaceutical companies for alleged fraudulent 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CPS

Q: Tell us some interesting details about your company’s history.

At CPS Solutions, LLC. (CPS), we’ve been partnering with healthcare organizations to transform pharmacy results for over 50 years.

In

Read More »

Senate, House Appropriators Agree on Budget for Office of Pharmacy Affairs but Have Different Priorities

Senate and House appropriators have agreed on funding for HHS and the office within it that oversees 340B, but they appear to have different regulatory priorities.
While it appears that Senate and House appropriators have agreed on a funding level for the office that oversees the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer